Valiglurax
Valiglurax (VU2957), also known as VU0652957 and VU2957, is a potent, selective, CNS penetrant, and orally bioavailable mGlu4 PAM. VU2957 possessed attractive in vitro and in vivo pharmacological and DMPK properties across species. VU2957 was evaluated as a preclinical development candidate for the treatment of Parkinson’s disease.
Product Specifications
CAS Number
1976050-09-5
Stability
≥ 2 years
Purity
>98% (HPLC)
Weight
329.28
Molecular Formula
C16H10F3N5
Notes
Research use only, not for human use.
Receptor
GluR
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS1425985-01 0.02 mg (E-Coli)
Recombinant Cat Growth arrest and DNA damage-inducible protein GADD45 alpha (GADD45A)
Sign In for Pricing
View Details MBS1425985-02 0.1 mg (E-Coli)
Recombinant Cat Growth arrest and DNA damage-inducible protein GADD45 alpha (GADD45A)
Sign In for Pricing
View Details